Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: New York NY, Hackensack NJ, The Bronx NY,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase3, Recruiting
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
for
Glomerular Disease, Proteinuria
Location: Jersey City NJ, Columbus GA, Saint Louis MO, Tampa FL,
Sponsor: Angion Biomedica Corp
Sex: All
Age: 18+
Code: NCT04939116
Phase2, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Jersey City NJ, Brooklyn NY, College Point NY,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase2, Phase3, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: New York NY, The Bronx NY, Mineola NY, New Brunswick NJ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: New York NY, East Brunswick NJ, Fairfax VA, Columbus OH,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06303505
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pediatric Residency Training On Tobacco
for
Tobacco Use Disorder
Location: Brooklyn NY, New York City NY, Jersey City NJ,
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sex: All
Age: 0+
Code: NCT00098215
Phase2, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: New York NY, Lake Success NY, Neptune City NJ,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: New York NY, Neptune City NJ, Stamford CT, Commack NY,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase3, Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Union City NJ, The Bronx NY, Hamden CT, Glen Burnie MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase2, Recruiting
ERP to Improve Functioning in Veterans With OCD
for
Obsessive Compulsive Disorder (OCD),
Location: New York NY, East Orange NJ, The Bronx NY, Northport NY,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05240924
Recruiting
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
for
Kidney Disease, Chronic
Location: New York NY, Bridgewater NJ, Philadelphia PA, Upland PA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06531824
Phase3, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: New York NY, The Bronx NY, Lake Success NY,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: New York NY, The Bronx NY, Lake Success NY,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase3, Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
for
In-Stent Restenosis, Cardiovascular Diseases,
Location: New York NY, New York City NY, Bronx NY, New Haven CT,
Sponsor: Concept Medical Inc.
Sex: All
Age: 18 - 70+
Code: NCT05908331
Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: New York NY, New Hyde Park NY, Morristown NJ,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant